299 related articles for article (PubMed ID: 29088219)
1. Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.
Mogire RM; Akala HM; Macharia RW; Juma DW; Cheruiyot AC; Andagalu B; Brown ML; El-Shemy HA; Nyanjom SG
PLoS One; 2017; 12(10):e0186364. PubMed ID: 29088219
[TBL] [Abstract][Full Text] [Related]
2.
Ochora DO; Mogire RM; Masai RJ; Yeda RA; Mwakio EW; Amwoma JG; Wakoli DM; Yenesew A; Akala HM
Heliyon; 2023 Aug; 9(8):e18863. PubMed ID: 37583763
[TBL] [Abstract][Full Text] [Related]
3. A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast.
Bispo NA; Culleton R; Silva LA; Cravo P
PLoS One; 2013; 8(3):e59288. PubMed ID: 23555651
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.
Dousti M; Manzano-Román R; Rashidi S; Barzegar G; Ahmadpour NB; Mohammadi A; Hatam G
Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33202000
[TBL] [Abstract][Full Text] [Related]
6. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
7. Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria.
Ali F; Wali H; Jan S; Zia A; Aslam M; Ahmad I; Afridi SG; Shams S; Khan A
Malar J; 2021 Aug; 20(1):335. PubMed ID: 34344361
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
9. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target.
Suksangpleng T; Leartsakulpanich U; Moonsom S; Siribal S; Boonyuen U; Wright GE; Chavalitshewinkoon-Petmitr P
Malar J; 2014 Apr; 13():149. PubMed ID: 24742318
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
[TBL] [Abstract][Full Text] [Related]
12. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
Ramakrishnan G; Chandra N; Srinivasan N
Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
[TBL] [Abstract][Full Text] [Related]
13. Repositioning: the fast track to new anti-malarial medicines?
Lotharius J; Gamo-Benito FJ; Angulo-Barturen I; Clark J; Connelly M; Ferrer-Bazaga S; Parkinson T; Viswanath P; Bandodkar B; Rautela N; Bharath S; Duffy S; Avery VM; Möhrle JJ; Guy RK; Wells T
Malar J; 2014 Apr; 13():143. PubMed ID: 24731288
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
15. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
16. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
[TBL] [Abstract][Full Text] [Related]
17. Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax.
Ferreira LT; Rodrigues J; Cassiano GC; Tavella TA; Tomaz KCP; Baia-da-Silva DC; Souza MF; Lima MNDN; Mottin M; Almeida LD; Calit J; Puça MCSB; Melo GC; Bargieri DY; Lopes SCP; Lacerda MVG; Bilsland E; Sunnerhagen P; Neves BJ; Andrade CH; Cravo PVL; Costa FTM
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601162
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum proteome changes in response to doxycycline treatment.
Briolant S; Almeras L; Belghazi M; Boucomont-Chapeaublanc E; Wurtz N; Fontaine A; Granjeaud S; Fusaï T; Rogier C; Pradines B
Malar J; 2010 May; 9():141. PubMed ID: 20500856
[TBL] [Abstract][Full Text] [Related]
19. THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.
Goto Y; Kamihira R; Nakao Y; Nonaka M; Takano R; Xuan X; Kato K
J Parasitol; 2021 Mar; 107(2):284-288. PubMed ID: 33844839
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
